GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease

Summary

The study will evaluate the dose response, safety, and pharmacokinetics of GSK573719 compared with placebo in subjects with COPD.

Timeline

Start

2009-09-01

Primary completion

2010-03-01

Completion

2010-03-15

Publications

• Background Donohue JF, Anzueto A, Brooks J, Mehta R, Kalberg C, Crater G. A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD. Respir Med. 2012 Jul;106(7):970-9. doi: 10.1016/j.rmed.2012.03.012. Epub 2012 Apr 10.

Drugs

Indications